Department of Justice Hinders Medical Marijuana Research

Slow walked by Attorney General Jeff Sessions and the Department of Justice (DOJ), more than 25 federal applications to cultivate cannabis for research purposes have effectively been halted.

After first asking Congress to undo federal medical marijuana protections in May, Sessions is now tackling the root of the problem – scientific research.

Historically, Sessions has been no fan of medical marijuana. When Sessions was questioned by the Judiciary Committee during his confirmation hearing, Sessions noted:

“I will defer to the American Medical Association and the researchers at the National Institutes of Health and elsewhere about the medical effects of marijuana. Without having studied the relevant regulations in depth, I cannot say whether they may need to be eased in order to advance research; but, I will review this.”

More than a year ago, when the Atty. Gen. was just Sen. Jefferson Beauregard Sessions III from Alabama, the Drug Enforcement Administration (DEA) germinated an application process for cultivators wanting to grow quality cannabis for research purposes. Now a mandated part of the research process, the DEA is required to get approval from the DOJ…

Continue reading at

About is the leading cannabis-related message forum and news site for in-depth, comprehensive cannabis strain and product education, marijuana media, growshop information and pricing. has been in operation since 1995 and is owned and operated by, the most widely used medical and recreational marijuana dispensary locator in the industry.

Leave a Reply

Your email address will not be published. Required fields are marked *